Відмінності між версіями «Uk.two 3 Pharmacokinetic data suggest that»
(Створена сторінка: Clinicians and customers might be reassured that this method of contraception is effective when left in utero for 5 years.M Harrison-Woolrych Senior healthcare...) |
м |
||
| Рядок 1: | Рядок 1: | ||
| − | + | BMJ 1998;316:l671. (30 May perhaps.) 2 Sivin I, El Mahgoub S, McCarthy T, Mishell DR Jr, Shoupe D, Alvarez F, et al. Long-term contraception using the levonorgestrel 20 mcg/day (LNg20) plus the Copper T 380 Ag intrauterine devices: a five year [http://www.medchemexpress.com/6-FAM.html 6-Carboxyfluorescein structure] randomised study. Contraception 1990;42:361-78. 3 Sivin I, Stern J, Coutinho E, Mattos C, El Mahgoub S, Diaz S, et al. Prolonged intrauterine contraception: a seven year randomised study from the levonorgestrel 20 mcg/day (LNg20) and also the Copper T 380 Ag IUDs. Contraception 1991;44:473-80.Discrimination against gay and lesbian doctors goes against GMC's guidanceEditor--As co-chairs in the Gay and Lesbian Association of Physicians and Dentists (GLADD) we have been concerned about an anonymous letter published in Profession Concentrate various months ago.1 It was by a gay medical professional within a coaching post and raises a number of significant difficulties. Firstly, because the writer pointed out, gay and lesbian physicians in the armed solutions are liable to dismissal for no other explanation than their sexuality. This occurred to certainly one of our members in 1997 after he was "outed" by a tabloid newspaper. Secondly, doctors inside the armed solutions are necessary to report service personnel whom they know to become homosexual even when this data has been acquired throughout a clinical consultation and in the understanding that the particular person concerned will likely be dismissed. In any other context such breach of confidentiality could amount to skilled misconduct. This concern is relevant to all physicians because it erodes the self-assurance of gay and lesbian individuals in the profession as a complete and is clearly inimical to very good healthcare practice. We think that instant action is necessary by the government, the armed solutions, plus the Common Healthcare Council. Thirdly, some gay and lesbian doctors in training within the NHS are still reluctant to be open about their sexuality for worry of discrimination by colleagues. We can supply them some comfort by pointing to the General Health-related Council's guidance to all physicians, which states: "You have to not discriminate against your colleagues, such as medical doctors applying for posts, mainly because of your views of their life-style, culture, beliefs, race, colour, sex, sexuality or age."2 We recognise, however, that practice may be very various.Susan Bewley Consultant obstetrician David Harvey Professor of paediatrics and [http://www.medchemexpress.com/Bergaptol.html 4-Hydroxybergapten price] neonatal medicine GLADD, PO Box 5606, London W4 1WY1 Not coming out. BMJ 1997;classified suppl:2. (13 December.) two General Medical Council. Duties of a physician. Excellent healthcare practice.United kingdom.two 3 Pharmacokinetic data recommend that the prices of release of levonorgestrel by both the old along with the new formulations are comparable more than five years, so these information are supportive. The updated item data for the levonorgestrel intrauterine device will allow a duration of use of 5 years and state that the device features a pregnancy price of much less than 1 per 100 woman years. Clinicians and users could be reassured that this approach of contraception is helpful when left in utero for five years.M Harrison-Woolrych Senior medical assessor J M Raine Group manager Medicines Handle Agency, London SW8 5NQ1 Mansour D, Guillebaud J. | |
Поточна версія на 02:12, 20 січня 2018
BMJ 1998;316:l671. (30 May perhaps.) 2 Sivin I, El Mahgoub S, McCarthy T, Mishell DR Jr, Shoupe D, Alvarez F, et al. Long-term contraception using the levonorgestrel 20 mcg/day (LNg20) plus the Copper T 380 Ag intrauterine devices: a five year 6-Carboxyfluorescein structure randomised study. Contraception 1990;42:361-78. 3 Sivin I, Stern J, Coutinho E, Mattos C, El Mahgoub S, Diaz S, et al. Prolonged intrauterine contraception: a seven year randomised study from the levonorgestrel 20 mcg/day (LNg20) and also the Copper T 380 Ag IUDs. Contraception 1991;44:473-80.Discrimination against gay and lesbian doctors goes against GMC's guidanceEditor--As co-chairs in the Gay and Lesbian Association of Physicians and Dentists (GLADD) we have been concerned about an anonymous letter published in Profession Concentrate various months ago.1 It was by a gay medical professional within a coaching post and raises a number of significant difficulties. Firstly, because the writer pointed out, gay and lesbian physicians in the armed solutions are liable to dismissal for no other explanation than their sexuality. This occurred to certainly one of our members in 1997 after he was "outed" by a tabloid newspaper. Secondly, doctors inside the armed solutions are necessary to report service personnel whom they know to become homosexual even when this data has been acquired throughout a clinical consultation and in the understanding that the particular person concerned will likely be dismissed. In any other context such breach of confidentiality could amount to skilled misconduct. This concern is relevant to all physicians because it erodes the self-assurance of gay and lesbian individuals in the profession as a complete and is clearly inimical to very good healthcare practice. We think that instant action is necessary by the government, the armed solutions, plus the Common Healthcare Council. Thirdly, some gay and lesbian doctors in training within the NHS are still reluctant to be open about their sexuality for worry of discrimination by colleagues. We can supply them some comfort by pointing to the General Health-related Council's guidance to all physicians, which states: "You have to not discriminate against your colleagues, such as medical doctors applying for posts, mainly because of your views of their life-style, culture, beliefs, race, colour, sex, sexuality or age."2 We recognise, however, that practice may be very various.Susan Bewley Consultant obstetrician David Harvey Professor of paediatrics and 4-Hydroxybergapten price neonatal medicine GLADD, PO Box 5606, London W4 1WY1 Not coming out. BMJ 1997;classified suppl:2. (13 December.) two General Medical Council. Duties of a physician. Excellent healthcare practice.United kingdom.two 3 Pharmacokinetic data recommend that the prices of release of levonorgestrel by both the old along with the new formulations are comparable more than five years, so these information are supportive. The updated item data for the levonorgestrel intrauterine device will allow a duration of use of 5 years and state that the device features a pregnancy price of much less than 1 per 100 woman years. Clinicians and users could be reassured that this approach of contraception is helpful when left in utero for five years.M Harrison-Woolrych Senior medical assessor J M Raine Group manager Medicines Handle Agency, London SW8 5NQ1 Mansour D, Guillebaud J.
